Maternal tuberculosis: A risk factor for mother-to-child transmission of human immunodeficiency virus

Journal of Infectious Diseases

Volumn 203, Issue 3, 2011, Pages 358-363

  Gupta, Amita ^a   Bhosale, Ramesh ^a,b   Kinikar, Arti ^a,b   Gupte, Nikhil ^a   Bharadwaj, Renu ^a,b   Kagal, Anju ^a,b   Joshi, Suvarna ^b   Khandekar, Medha ^a,b   Karmarkar, Alaka ^b   Kulkarni, Vandana ^a   Sastry, Jayagowri ^a   Mave, Vidya ^a   Suryavanshi, Nishi ^a   Thakar, Madhuri ^c   Kulkarni, Smita ^c   Tripathy, Srikanth ^c   Sambarey, Pradeep ^a,b   Patil, Sandesh ^a   Paranjape, Ramesh ^c   Bollinger, Robert C ^a   Jamkar, Arun ^a,b   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Byramji Jeejeebhoy Medical College (BJMC)   (India)

^c NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ADULT; ARTICLE; BIRTH WEIGHT; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE DRUG DOSE; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 79751496879     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq064     Document Type: Article

References (20)

1. World Health Organization. Global tuberculosis control: A short update to the 2009. Available at http://www.who.int/tb/publications/global-report/2009/ update/en/index.html. Accessed 5 September 2010.
2. United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: November 2009. Available at http://data.unaids.org/pub/Report/2009/JC1700-Epi-update-2009-en.pdf. Accessed 5 September 2010.
3. Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 2007; 45:241-9.
4. Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: Considerations for resource-limited settings. Lancet Infect Dis 2004; 4:155-65. (Pubitemid 38293139)
5. Adhikari M. Tuberculosis and tuberculosis/HIV co-infection in pregnancy. Semin Fetal Neonatal Med 2009; 14:234-40.
6. Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr 2009; 21: 94-101.
7. Bedri A, Gudetta B, Isehak A, et al; for the Six Week Extended-Dose Nevirapine (SWEN) Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: An analysis of three randomised controlled trials. Lancet 2008; 372:300-13.
8. World Health Organization. TB/HIV: A clinical manual. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
9. World Health Organization. WHO three I's meeting: Intensified case finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Available at http://www.who.int/tb/publications/ 2009/who-3is-meeting-report.pdf. Accessed 5 September 2010.
10. Pillay T, Adhikari M, Coovadia HM, Moodley J, Khan M, Sullivan JL. In utero HIV infection in pregnancies complicated by tuberculosis in Durban, South Africa. Arch Dis Child Fetal Neonatal Ed 2004; 89:F468-9.
11. Day JH, Grant AD, Fielding KL, et al. Does tuberculosis increase HIV load? J Infect Dis 2004; 190:1677-84.
12. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: Role of immune activation. J Immunol 1996; 157:1271-8. (Pubitemid 126449644)
13. Zhang Y, Nakata K, Weiden M, Rom WN. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995; 95:2324-31.
14. Toossi Z, Mayanja-Kizza H, Hirsch CS, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001; 123:233-8. (Pubitemid 32174774)
15. Ayisi JG, van Eijk AM, Newman RD, et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004; 10:643-52. (Pubitemid 38420295)
16. Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001; 14:753-77. (Pubitemid 32979630)
17. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994; 7:727-33.
18. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71. (Pubitemid 44924494)
19. Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009; 200:1022-30.
20. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and the treatment of tuberculosis. BMC Public Health 2008; 8:15.